Table 5:
ESBL Resistance to combination therapy of Sultan Qaboos University Hospital paediatric patients
| Isolates | CN + CEP | CN + TAZ | CN + CIP | CN + F | AK + CEP | AK + TAZ | AK + CIP | AK+ F | CIP + TAZ | CIP + CEP | CIP + F | F + TAZ | F + CEP |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Klebsiella pneumoniae | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 1 | 7 | 7 |
| E. Coli | 6 | 1 | 6 | 0 | 1 | 0 | 1 | 0 | 1 | 6 | 0 | 0 | 0 |
| Total | 6 (46) | 1 (8) | 6 (46) | 0 | 1 (8) | 0 | 1 (8) | 0 | 2 (16) | 7 (54) | 1 (8) | 7 (54) | 7 (54) |
CN + CEP = gentamicin+ cefepime, CN + TAZ =gentamicin+ tazocin, CN + CIP = gentamicin+ ciprofloxacin, CN + F = gentamicin + nitrofurantoin AK + CEP = amikacin + cefepime, AK + TAZ = amikacin + tazocin, AK + CIP = amikacin + ciprofloxacin, AK + F = amikacin + nitrofurantoin, CIP + TAZ = ciprofloxacin + tazocin, CIP + CEP = ciprofloxacin + cefepime, CIP + F = ciprofloxacin + nitrofurantoin, F + TAZ = nitrofurantoin + tazocin, F + CEP = nitrofurantoin + cefepime